From SARS-CoV to Coronavirus Disease 2019 (COVID-19) - A Brief Review

  • Daga M
N/ACitations
Citations of this article
69Readers
Mendeley users who have this article in their library.

Abstract

Emerging and reemerging pathogens are global challenges for public health. For the third time in as many decades, a zoonotic coronavirus has crossed species to infect human populations. Given the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) outbreak in 2002 and the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) outbreak in 2012, 2019-nCoV is the third coronavirus to emerge in the human population in the past 18 years-an outbreak that has raised great hue and cry globally as it has sickened thousands of people across the world. This novel coronavirus was named as COVID-19 which stands for Corona Virus Disease 2019. The 2019-nCoV originated from Wuhan, Hubei Province, China beginning in December 2019. The World Health Organization declared it as a Public Health Emergency of International Concern. At that point, there were 9826 confirmed cases globally, with 213 deaths. Of these, 9720 cases were in China; outside of China, health authorities reported 106 confirmed cases in 19 countries. As of February 2, the WHO updated the count, reporting 14 557 confirmed cases from 24 countries-14 411 of them in China. In this review we focus our attention on Covid-19 and how different this epidemic is from the previous two outbreak caused by coronavirus.

Cite

CITATION STYLE

APA

Daga, M. K. (2020). From SARS-CoV to Coronavirus Disease 2019 (COVID-19) - A Brief Review. Journal of Advanced Research in Medicine, 06(04), 1–9. https://doi.org/10.24321/2349.7181.201917

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free